The Analytical Core will serve as a resource and service for carrying out all laboratory analyses related to Projects l, Il and Ill in this proposal. The core has developed and validated sample collection and preparation procedures for blood, fecal, mononuclear cells, tissue blocks, and rectal biopsies and will continue to optimize methods for measuring the surrogate endpoint biomarkers (SEBs) to be used in the three projects within this proposal. Endpoints to be analyzed by the Analytical Core will include blood and fecal bile acids, cell proliferation measured by proliferating cell nuclear antigen (PCNA), protein kinase C (PKC) enzymatic activity and isotype expression in rectal mucosal biopsies, and DNA ploidy in adenomatous polyps. The Analytical Core will oversee and coordinate the collection and processing of all samples related to this Program Project at the various participating hospitals and clinics. In addition, the Analytical core will be responsible for the training of personnel involved in the collection and processing of study samples. It will perform actual assays and will work closely with the Biometry Core (B) to provide data for reporting and interpretation. Quality assurance and quality control procedures will continue to be developed by the Analytical Core which will be supervised by the Biometry Core for sample acquisition, processing, and Core which will be supervised the Biometry Core for sample acquisition, processing, and analysis procedures included in each of the clinical projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA041108-13
Application #
6102268
Study Section
Project Start
1999-03-01
Project End
2000-09-13
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Lance, Peter; Alberts, David S; Thompson, Patricia A et al. (2017) Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention. Cancer Prev Res (Phila) 10:45-54
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst 108:
Jacobs, Elizabeth T; Haussler, Mark R; Alberts, David S et al. (2016) Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations. Cancer Prev Res (Phila) 9:589-97
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst 108:
Hibler, Elizabeth A; Sardo Molmenti, Christine L; Dai, Qi et al. (2016) Physical activity, sedentary behavior, and vitamin D metabolites. Bone 83:248-255
Minasian, Lori M; Tangen, Catherine M; Wickerham, D Lawrence (2015) Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. Semin Oncol 42:748-63
Bea, Jennifer W; Jurutka, Peter W; Hibler, Elizabeth A et al. (2015) Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64:447-59
Hibler, Elizabeth A; Klimentidis, Yann C; Jurutka, Peter W et al. (2015) CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence. Nutr Cancer 67:1131-41
Molmenti, Christine L Sardo; Hibler, Elizabeth A; Ashbeck, Erin L et al. (2014) Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control 25:1387-95

Showing the most recent 10 out of 149 publications